Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Nov 1;293(6555):1117–1118. doi: 10.1136/bmj.293.6555.1117

Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

J P Miller, E B Faragher
PMCID: PMC1341843  PMID: 3094799

Full text

PDF
1117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchi Porro G., Lazzaroni M., Petrillo M., De Nicola C. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet. 1984 Sep 22;2(8404):698–698. doi: 10.1016/s0140-6736(84)91258-3. [DOI] [PubMed] [Google Scholar]
  2. Dronfield M. W., Batchelor A. J., Larkworthy W., Langman M. J. Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. Gut. 1979 Jun;20(6):526–530. doi: 10.1136/gut.20.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frislid K., Aadland E., Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol. 1986 Jan;21(1):119–122. doi: 10.3109/00365528609034634. [DOI] [PubMed] [Google Scholar]
  4. Gray G. R., Smith I. S., Mackenzie I., Gillespie G. Long term cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology. 1978 Feb;74(2 Pt 2):397–401. [PubMed] [Google Scholar]
  5. Guslandi M., Cambielli M., Tittobello A. Carbenoxolone maintenance in cimetidine-healed patients. Scand J Gastroenterol. 1980;15(3):369–371. doi: 10.3109/00365528009181485. [DOI] [PubMed] [Google Scholar]
  6. Hamilton I., O'Connor H. J., Wood N. C., Bradbury I., Axon A. T. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut. 1986 Jan;27(1):106–110. doi: 10.1136/gut.27.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamilton I., Worsley B. W., O'Connor H. J., Axon A. T. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut. 1983 Dec;24(12):1148–1151. doi: 10.1136/gut.24.12.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hansky J., Korman M. G. Long-term cimetidine in duodenal ulcer disease. Dig Dis Sci. 1979 Jun;24(6):465–467. doi: 10.1007/BF01299829. [DOI] [PubMed] [Google Scholar]
  9. Hetzel D. J., Shearman D. J., Hecker R., Sheers R. Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial. Med J Aust. 1979 Jun 2;1(11):529–531. [PubMed] [Google Scholar]
  10. Ippoliti A., Elashoff J., Valenzuela J., Cano R., Frankl H., Samloff M., Koretz R. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology. 1983 Oct;85(4):875–880. [PubMed] [Google Scholar]
  11. Kang J. Y., Piper D. W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. Digestion. 1982;23(2):73–79. doi: 10.1159/000198690. [DOI] [PubMed] [Google Scholar]
  12. Marks I. N., Wright J. P., Lucke W., Girdwood A. H. Relapse rates after initial ulcer healing with sucralfate and cimetidine. Scand J Gastroenterol. 1982 Apr;17(3):429–432. doi: 10.3109/00365528209182081. [DOI] [PubMed] [Google Scholar]
  13. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  14. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  15. McLean A. J., Harrison P. M., Ioannides-Demos L., Byrne A. J., McCarthy P., Dudley F. J. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. Aust N Z J Med. 1985 Jun;15(3):367–374. doi: 10.1111/j.1445-5994.1985.tb04065.x. [DOI] [PubMed] [Google Scholar]
  16. Moshal M. G., Gregory M. A., Pillay C., Spitaels J. M. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol. Scand J Gastroenterol Suppl. 1979;54:48–51. [PubMed] [Google Scholar]
  17. Pounder R. E. Duodenal ulcers that will not heal. Gut. 1984 Jul;25(7):697–702. doi: 10.1136/gut.25.7.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pounder R. E. Model of medical treatment for duodenal ulcer. Lancet. 1981 Jan 3;1(8210):29–30. doi: 10.1016/s0140-6736(81)90128-8. [DOI] [PubMed] [Google Scholar]
  19. Ström M., Gotthard R., Bodemar G., Walan A. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol. 1981;16(5):593–602. doi: 10.3109/00365528109182017. [DOI] [PubMed] [Google Scholar]
  20. Yeomans N. D. Relapse of duodenal ulcers after cimetidine treatment: idol 'indecently' assaulted? Aust N Z J Med. 1985 Jun;15(3):291–292. doi: 10.1111/j.1445-5994.1985.tb04038.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES